Document:

Form of Stock-Settled Appreciation Right Agreement

 Exhibit 10.53 

PERRY ELLIS INTERNATIONAL, INC. 

STOCK-SETTLED STOCK APPRECIATION RIGHT AGREEMENT 

FOR 

XXXXXX 

Agreement 

1. Grant of Stock Appreciation Right. Perry Ellis International, Inc. (the “Company”) hereby grants to XXXX (the
“Grantee”) as of XXXXX (“Date of Grant”) pursuant to the Company’s 2005 Long-Term Incentive Compensation Plan (the “Plan”), as amended and restated, and which is incorporated herein for all purposes, a
stock-settled stock appreciation right (the “SSAR”) on XXXXX shares of the Company’s Common Stock, $0.01 par value per share (the “Shares”). The exercise price of the SSAR is $XXXXX (the “Exercise Price”).
The Grantee hereby acknowledges receipt of a copy of the Plan and agrees to be bound by all of the terms and conditions hereof and thereof and all applicable laws and regulations. The SSAR shall be subject to the terms and conditions set forth
herein. 
 2. Definitions. Unless otherwise provided herein, terms used herein that are defined in the Plan and not
defined herein shall have the meanings attributed thereto in the Plan. 
 3. Compensation under the SSAR. Upon the
exercise of the SSAR, in whole or in part, in accordance with Section 5 below, the Grantee shall receive as compensation a number of Shares equal to (A x (B – C)) / B, where: 

 

					
	A	  	=	  	the number of Shares underlying the SSAR being exercised;
			
	B	  	=	  	the fair market value of a Share on the date of such exercise; and
			
	C	  	=	  	the Exercise Price.

 Fractional Shares
shall be fully disregarded. 
 4. Exercise Schedule. Except as otherwise provided in Sections 6 or 9 of this Agreement,
or in the Plan, the SSAR is exercisable in installments as provided below, which shall be cumulative. To the extent that the SSAR has become exercisable with respect to a percentage of Shares as provided below, the SSAR may thereafter be exercised
by the Grantee, in whole or in part, at any time or from time to time prior to the expiration of the SSAR as provided herein. The following table indicates each date (the “Vesting Date”) upon which the Grantee shall be entitled to exercise
the SSAR with respect to the percentage of Shares granted as indicated beside the date, provided that the Continuous Service of the Grantee continues through and on the applicable Vesting Date: 

 

			
	 Number/Percentage of Shares Subject to the SSAR
	  	Vesting Date
	 XXXX/XX%
	  	XXXXXXX
	 XXXX/XX%
	  	XXXXXXX
	 XXXX/XX%
	  	XXXXXXX
	 XXXX/100%
	  	XXXXXXX

  

 1 

 Except as otherwise specifically provided herein, there shall be no proportionate or partial vesting in the
periods prior to each Vesting Date, and all vesting shall occur only on the appropriate Vesting Date. Upon the termination of the Grantee’s Continuous Service with the Company and its Related Entities, any unvested portion of the SSAR shall
terminate and be null and void. 
 5. Method of Exercise. The vested portion of the SSAR shall be exercisable in whole or
in part in accordance with the exercise schedule set forth in Section 4 hereof by written notice which shall state the election to exercise the SSAR, the number of Shares in respect of which the SSAR is being exercised, and such other
representations and agreements as to the holder’s investment intent with respect to such Shares as may be required by the Company pursuant to the provisions of the Plan. Such written notice shall be signed by the Grantee and shall be delivered
in person or by certified mail to the Secretary of the Company. The SSAR shall be deemed to be exercised after both (a) receipt by the Company of such written notice and (b) arrangements that are satisfactory to the Committee, in its sole
discretion, have been made for Grantee’s applicable minimum statutory withholding rates required by the relevant tax authority or authorities. No Shares shall be issued pursuant to the SSAR unless and until such issuance and such exercise shall
comply with all relevant provisions of applicable law, including the requirements of any stock exchange upon which the Shares then may be traded. 

6. Termination of the SSAR. Any unexercised portion of the SSAR shall automatically and without notice terminate and become null
and void at the time of the earliest to occur of the following: 
 (a) unless the Committee otherwise determines in writing in
its sole discretion, three months after the date on which the Grantee’s Continuous Service with the Company and its Related Entities is terminated for any reason other than by reason of (i) termination of the Grantee’s Continuous
Service by the Company or a Related Entity for Cause, (ii) a Disability of the Grantee as determined by a medical doctor satisfactory to the Committee, or (iii) the Grantee’s death; 

(b) immediately upon the termination of the Grantee’s Continuous Service with the Company and its Related Entities for Cause;

 (c) twelve months after the date on which the Grantee’s Continuous Service with the Company and its Related Entities is
terminated by reason of a Disability as determined by a medical doctor satisfactory to the Committee; 
 (d) twelve months after
the date of termination of the Grantee’s Continuous Service with the Company and its Related Entities by reason of the death of the Grantee (or, if later, three months after the date on which the Grantee shall die if such death shall occur
during the one year period specified in paragraph (c) of this Section 6); or 
 (e) the seventh anniversary of the
date as of which the SSAR is granted. 
 7. Transferability. Unless otherwise determined by the Committee, the SSAR
granted hereby is not transferable otherwise than by will or under the applicable laws of descent and distribution, and during the lifetime of the Grantee the SSAR shall be exercisable only by the

  

 2 

 
Grantee, or the Grantee’s guardian or legal representative. In addition, the SSAR shall not be assigned, negotiated, pledged or hypothecated in any way (whether by operation of law or
otherwise), and the SSAR shall not be subject to execution, attachment or similar process. Upon any attempt to transfer, assign, negotiate, pledge or hypothecate the SSAR, or in the event of any levy upon the SSAR by reason of any execution,
attachment or similar process contrary to the provisions hereof, the SSAR shall immediately become null and void. The terms of the SSAR shall be binding upon the executors, administrators, heirs, successors and assigns of the Grantee. 

8. No Rights of Stockholders. Neither the Grantee nor any personal representative (or beneficiary) shall be, or shall have any of
the rights and privileges of, a stockholder of the Company with respect to any shares of Stock issuable upon the exercise of the SSAR, in whole or in part, prior to the date of exercise of the SSAR. 

9. Acceleration of Exercisability of SSAR. 

(a) This SSAR shall become immediately fully exercisable in the event that, prior to the termination of the SSAR pursuant to
Section 6 hereof, and during the Grantee’s Continuous Service, there is a “Change in Control”, as defined in Section 9(b) of the Plan. 

(b) Notwithstanding the foregoing, if in the event of a Change in Control the successor company assumes or substitutes for the SSAR, the
vesting of the SSAR shall not be accelerated as described in Section 9(a). For the purposes of this paragraph, the SSAR shall be considered assumed or substituted for if, following the Change in Control, the SSAR or substituted SSAR confers an
economically equivalent stock appreciation right with respect to each Share subject to the SSAR immediately prior to the Change in Control; provided, however, that if the consideration received in the transaction constituting a Change in Control is
not solely common stock of the successor company or its parent or subsidiary, the Committee may, with the consent of the successor company, or its parent or subsidiary, provide that the consideration to be received upon the exercise or vesting of
the SSAR will be solely common stock of the successor company or its parent or subsidiary substantially equal in fair market value to the per share consideration received by holders of Shares in the transaction constituting a Change in Control. The
determination of such substantial equality of value of consideration shall be made by the Committee in its sole discretion and its determination shall be conclusive and binding. 

10. No Right to Continued Employment. Neither the SSAR nor this Agreement shall confer upon the Grantee any right to continued
employment or service with the Company. 
 11. Law Governing. This Agreement shall be governed in accordance with and
governed by the internal laws of the State of Florida. 
 12. Interpretation / Provisions of Plan Control. This Agreement
is subject to all the terms, conditions and provisions of the Plan, including, without limitation, the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan adopted by the Committee as may be in effect
from time to time. If and to the extent that this Agreement conflicts or is inconsistent with the terms, conditions and provisions of the Plan, the Plan shall control, and this Agreement shall be deemed to be modified accordingly. The Grantee
accepts the SSAR subject to all of the terms and provisions of the Plan and this Agreement. The undersigned Grantee hereby accepts as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under
the Plan and this Agreement, unless shown to have been made in an arbitrary and capricious manner. 
  

 3 

 13. Notices. Any notice under this Agreement shall be in writing and shall be deemed
to have been duly given when delivered personally or when deposited in the United States mail, registered, postage prepaid, and addressed, in the case of the Company, to the Company’s General Counsel at Perry Ellis International, Inc., 3000
N.W. 107 Avenue, Miami, FL 33172, or if the Company should move its principal office, to such principal office, and, in the case of the Grantee, to the Grantee’s last permanent address as shown on the Company’s records, subject to the
right of either party to designate some other address at any time hereafter in a notice satisfying the requirements of this Section. 

14. Internal Revenue Code Section 409A. The SSAR granted hereunder is intended to be exempt from Section 409A
of the Internal Revenue Code of 1986, as amended, and the Treasury regulations and other official guidance promulgated thereunder. 

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK 
  

 4 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement. 

 

			
	PERRY ELLIS INTERNATIONAL, INC.
		
	 By:
	 	  

		
	 Title:
	 	  

		
	 Date Signed:
	 	  

The Grantee acknowledges receipt of a copy of the Plan and represents that he or she has reviewed the provisions of the Plan and the SSAR Agreement in
their entirety, is familiar with and understands their terms and provisions, and hereby accepts the SSAR subject to all of the terms and provisions of the Plan and the SSAR Agreement. The Grantee further represents that he or she has had an
opportunity to obtain the advice of counsel prior to executing the SSAR Agreement. 
  

			
	GRANTEE
		
	 Signature:
	 	  

		
	 Print Name:
	 	  

		
	 Date Signed:
	 	  

 

 5Agreement, dated June 4, 2010 by and among SMTC Corporation

 Exhibit 10.1 

AGREEMENT 

This AGREEMENT (this “Agreement”) is entered into as of this 4th day of June 2010, by and among The Red Oak Fund, LP, a
Delaware limited partnership, and the persons and entities affiliated with it and listed on the signature pages hereof (collectively, “Red Oak”), Anton Simunovic and SMTC Corporation, a Delaware corporation (“SMTC”
or the “Company”). 
 WHEREAS, on the date hereof Red Oak is the beneficial owner of approximately 17% of the
outstanding shares of common stock of the Company, par value $0.01 per share (the “Common Stock”); 
 WHEREAS,
Red Oak has sent letters to the Company detailing certain proposals (the “Proposals”) Red Oak has requested the Company undertake related to the Company’s 2010 annual meeting of stockholders (the “2010 Annual
Meeting”), its board of directors (the “Board”) and certain other matters; 
 WHEREAS, the Company is
preparing its proxy statement (the “Proxy Statement”) for the 2010 Annual Meeting, and it has agreed to certain changes set forth in the Proposals which implicate the filing of the Proxy Statement; and 

WHEREAS, the Company and Red Oak desire to enter into an agreement relating to the Proposals and to expedite the filing and delivery of
the Proxy Statement. 
 NOW, THEREFORE, in consideration of the foregoing, the parties hereto agree as follows: 

1. Board Nominees. Red Oak hereby withdraws, effective upon the nomination to the Board of Directors of the persons
named in Section 3 as stated below and the Company hereby acknowledges the withdrawal of, (a) Clarke Bailey, Anton Simunovic and David Sandberg as proposed nominees to the Board for purposes of the 2010 Annual Meeting and (b) the
additional stockholder proposals set forth in Red Oak’s letter to the Company dated May 4, 2010. 
 2.
Number of Directors. There shall be no restrictions on the number of directors authorized by the Board in accordance with the Bylaws of the Company. 

3. 2010 Director Nominees. The Company and Red Oak agree that the nominees for director to be proposed by the
Nominating and Governance Committee of the Board for election at the 2010 Annual Meeting shall be Wayne McLeod, John Caldwell, John Marinucci, Alex Walker, Anton Simunovic and David Sandberg. The Company’s proxy materials will recommend
election of all the nominees. A seventh independent member who meets the Company’s director qualification criteria may be selected be the Board prior to or after the 2010 Annual Meeting and, if so selected prior to the 2010 Annual Meeting,
shall be proposed for election at the 2010 Annual Meeting. Red Oak, David Sandberg (in his capacity as a current director) and the David Sandberg and Anton Simunovic, if elected, shall support any

 
proposal to expand the Board to seven members provided such proposal is linked to the concurrent addition of an additional independent member of the Board. Other than as provided in this
Section 3, Red Oak hereby waives any right it may have to nominate a director or directors for election at the 2010 Annual Meeting and at the 2011 annual meeting of stockholders (the “2011 Annual Meeting”). 

4. Board Committees. Messrs. Sandberg and Simunovic, if elected, shall be considered for appointment to each of the
committees of the Board of Directors for which such nominee is qualified and from which such nominee is not prohibited from serving (by law, requirement of The Nasdaq Stock Market or otherwise) in the good faith discretion of the Governance and
Nominating Committee of the Board. Within 30 days of the 2010 Annual Meeting, the Governance and Nominating Committee shall make its recommendation to the full Board as to Board committee composition. Based upon such recommendations, the Board shall
appoint Board members to serve on Board committees within such 30-day period. 
 5. Tax Benefits Preservation
Plan. The Board will adopt, no later than the date of the 2010 Annual Meeting, and present to the stockholders of the Company for approval at the 2010 Annual Meeting a customary Tax Benefits Preservation Plan in substantially the form (as
determined by a majority of the Board of Directors excluding John Caldwell and David Sandberg) of the draft provided to Red Oak on May 13, 2010 (the “NOL Rights Plan”). 

6. Voting and Other Agreements. 

(a) Red Oak hereby agrees to vote all of its shares of Common Stock at the 2010 Annual Meeting (i) in favor of each
of those individuals nominated as directors as set forth in Section 3 above, (ii) in favor of approval of the NOL Rights Plan, (iii) in favor of approval of the 2010 Equity Incentive Plan in substantially the form presented to the
Board on May 10, 2010, and (iv) in favor of each other proposal consistent with the terms hereof contained in the Proxy Statement in the manner that the Board recommends in the Proxy Statement; 

(b) Red Oak hereby agrees to vote all of its shares of Common Stock at the 2011 Annual Meeting (i) in favor of each
of those individuals nominated by the Board as directors for approval at such meeting, and (ii) in favor of each other proposal contained in the Proxy Statement for such meeting (other than a proposed merger, sale of all or substantially all of
the assets of the Company, dissolution of the Company or the creation of a new class of stock) in the manner that the Board recommends in the Proxy Statement; and 

(c) Red Oak hereby agrees that through January 5, 2011 it shall not, and shall cause each affiliate not to, directly
or indirectly, sell, assign or otherwise transfer or dispose of its shares of Common Stock such that its ownership would be less than 5.5% of the outstanding Common Stock during such period. 

 

 -2- 

 7. Release of Claims. Red Oak and the Company hereby release and
forever discharge each other, and their respective directors, officers, partners, principals, employees and agents, from all claims and demands, rights and causes of action of any kind arising out of the 2010 Annual Meeting and the other subject
matter hereof and all other actions commenced, or any claims, whether asserted or unasserted, known or unknown as of the date hereof by or against the Company or Red Oak. Notwithstanding anything to the contrary in this paragraph, the foregoing
releases shall not affect, waive, limit, modify or in any other way change in any manner any obligation or liability of any party under this Agreement, any instrument or agreement executed and delivered pursuant to this Agreement, or any claims
arising from or related to breaches of fiduciary duty or similar claims on or after the date of this Agreement. 

8. Company Representations and Warranties. The Company represents and warrants to Red Oak as follows: 

(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of
Delaware. The Company has the full power and authority to execute, deliver and carry out the terms and provisions of this Agreement, and has taken all necessary action to authorize the execution, delivery and performance of this Agreement; and

 (b) This Agreement has been duly and validly authorized by the Board, and executed and delivered by the
Company and constitutes a valid and binding obligation of the Company, enforceable in accordance with its terms, and no other proceeding on the part of the Company is necessary to authorize the execution, delivery and performance of this Agreement.

 9. Red Oak Representations and Warranties. Each member of Red Oak represents and warrants to the
Company as follows: 
 (a) To the extent that Red Oak is an entity, it is duly organized, validly existing and in
good standing under the laws of the state in which it was incorporated or organized. It has the full power and authority to execute, deliver and carry out the terms and provisions of this Agreement, and has taken all necessary action to authorize
the execution, delivery and performance of this Agreement; and 
 (b) This Agreement has been duly and validly
authorized by Red Oak’s governing bodies, and executed and delivered by Red Oak and constitutes its valid and binding obligation, enforceable against Red Oak in accordance with its terms, and no other proceeding on its part is necessary to
authorize the execution, delivery and performance of this Agreement. 
 10. Standstill Agreement. Each
member of Red Oak agrees that, until ten days prior to any applicable deadline imposed by the rule described below or the certificate of incorporation and by-laws of the Company, in each case with respect to the Company’s 2012 annual meeting of
stockholders (the “Standstill Period”) and except as provided in this Agreement, neither it nor any of its affiliates or associates shall: 

(i) nominate any candidates for the Board of Directors of the Company; 

 

 -3- 

 (ii) call a special meeting of stockholders; 

(iii) submit a shareholder proposal under Rule 14a-8 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), or otherwise under the By-laws, as in effect from time to time, directly or indirectly, to the Company; (iii)file a proxy statement in opposition to the Company (except with respect to a proposed merger, sale of all
or substantially all of the assets of the Company, dissolution of the Company or the creation of a new class of stock) or otherwise solicit proxies or consents from any shareholders of the Company, except in response to a competing proxy
solicitation initiated and maintained by a third party not affiliated with Red Oak without the cooperation or encouragement of Red Oak; 

(iv) effect or seek (including, without limitation, entering into any discussions, negotiations, agreements or
understandings with any third person), offer or propose (whether publicly or otherwise) to effect, or cause or participate in, or in any way, advise, assist or encourage any other persons in connection with any of the foregoing; 

(v) vote its shares against any Company nominee for director at any special meeting of stockholders; or 

(vi) request, directly or indirectly, any amendment or waiver of any provision of this paragraph 10 (including this
sentence) by the Company or any of its agents or representatives. 
 11. Amendments and Waivers. No
amendment or waiver of any provision of this Agreement shall be valid and binding unless it is in writing and signed, in the case of an amendment, by the Company and Red Oak, or in the case of a waiver, by the party against whom the waiver is to be
effective. No waiver by any party of any breach or violation or, default under or inaccuracy in any representation, warranty or covenant hereunder, whether intentional or not, shall be deemed to extend to any prior or subsequent breach, violation,
default of, or inaccuracy in, any such representation, warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence. No delay or omission on the part of any party in exercising any
right, power or remedy under this Agreement shall operate as a waiver thereof. 
 12. Successors and
Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted assigns of the parties. Nothing in this Agreement, express or
implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this
Agreement. 
  

 -4- 

 13. Counterparts. This Agreement may be executed in any number of
counterparts, which may be exchanged by PDF or facsimile each of which shall be deemed an original, but all of which together shall constitute but one and the same instrument. This Agreement shall become effective when duly executed by each party
hereto. 
 14. Severability. Any term or provision of this Agreement that is invalid or unenforceable in
any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction.
In the event that any provision hereof would, under applicable law, be invalid or unenforceable in any respect, each party hereto intends that such provision shall be construed by modifying or limiting it so as to be valid and enforceable to the
maximum extent compatible with, and possible under, applicable law. 
 15. Governing Law. This Agreement,
the rights of the parties and all actions arising in whole or in part under or in connection herewith, shall be governed by and construed in all respects, including validity, interpretation and effect, in accordance with the laws of Delaware,
applicable to contracts executed and to be performed wholly within such state without giving effect to any choice or conflict of law provision or rule that would cause the application of the laws of any other jurisdiction. Each of the parties hereto
(a) consents to submit itself to the personal jurisdiction of the state courts in New York, New York in the event any dispute arises out of this Agreement or the transactions contemplated by this Agreement, (b) agrees that it shall not
attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, (c) agrees that it shall not bring any action relating to this Agreement or the transactions contemplated by this Agreement in any
court other than the state or federal courts in New York, New York, (d) agrees to waive any bonding requirement under any applicable law, in the case any other party seeks to enforce the terms by way of equitable relief and (e) each of the
parties irrevocably consents to service of process by first class certified mail, return receipt requested, postage prepaid, to the address of such parties’ principal place of business or as otherwise provided by applicable law. 

[Next page is the signature page.] 
  

 -5- 

 IN WITNESS WHEREOF, the undersigned parties have duly executed this Agreement as of the date
first written above. 
  

			
	THE RED OAK FUND, LP
		
	By:	 	 Red Oak Partners, LLC,
 its
general partner

		
	By:	 	 /s/ David Sandberg

	Name:	 	David Sandberg
	Title:	 	Managing Member
	
	RED OAK PARTNERS, LLC
		
	By:	 	 /s/ David Sandberg

	Name:	 	David Sandberg
	Title:	 	Managing Member
	
	DAVID SANDBERG
	
	 /s/ David Sandberg

	
	ANTON SIMUNOVIC
	
	 /s/ Anton Simunovic

	
	SMTC CORPORATION
		
	By:	 	 /s/ John E. Caldwell

	Name:	 	John E. Caldwell
	Title:	 	Chief Executive Officer and President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}]]